Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System (HALO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02033070
Recruitment Status : Unknown
Verified January 2014 by Virendra Joshi, Ochsner Health System. Recruitment status was: Not yet recruiting
The purpose of this study is to provide a tool for physicians to compare outcome data related to the use of the HALO Ablation Systems. This study is a single-center patient registry which will contribute to a framework for treatment and follow-up of patients with Barrett's Esophagus.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Adult patients presenting with esophageal intestinal metaplasia (IM), including the pathological subclasses of non-dysplastic IM, low-grade dysplasia (LGD) and high-grade dysplasia (HGD)
candidate for ablation of Barrett's Esophagus with the HALO Ablation System (Prospective)
received an ablation with the HALO Ablation System to treat Barrett's Esophagus (Retrospective)
candidate agrees to proposed follow-up schedule of yearly surveillance following treatment